The most common side effects of indinavir include:<ref>{{cite web|title=Crixivan<sup>®</sup> (indinavir sulfate) Capsules. Prescribing Information. Revised December 2013|url=http://www.merck.com/product/usa/pi_circulars/c/crixivan/crixivan_pi.pdf|publisher=Merck & Co., Inc.|accessdate=6 February 2014}}</ref>

 
* Gastrointestinal disturbances (abdominal pain, diarrhea, nausea, vomiting)

 
* General malaise and [[Fatigue (medical)|fatigue]]

 
* Nephrolithiasis/urolithiasis (the formation of [[kidney stone]]s), which sometimes may lead to more severe condition including [[Chronic kidney disease|kidney failure]]

 
* [[Metabolic]] alterations including [[hyperlipidemia]] ([[cholesterol]] or [[triglyceride]] elevations) and [[hyperglycemia]]

 
* Alterations in body shape ([[lipodystrophy]]), colloquially known as "Crix belly"<ref>{{cite journal | title=Protease inhibitors' metabolic side effects: cholesterol, triglycerides, blood sugar, and "Crix belly" | journal=AIDS Treatment News | issue=277 | pages=1&ndash;4 | year=1997 | pmid=11364559 | author1=Capaldini | first1=L }}</ref>

 


 
Indinavir inhibits urinary nitrous oxide production and may inhibit nitric oxide production.  Treatment with this drug is frequently associated with renal abnormalities, sterile leukocyturia, and reduced [[creatinine clearance]].<ref>M. Eira, M. Araujo and A.C. Seguro. [http://www.scielo.br/pdf/bjmbr/v39n8/6140.pdf Urinary NO<sub>3</sub> excretion and renal failure in indinavir-treated patients]. Brazilian Journal of Medical and Biological Research (2006) 39: 1065-1070.</ref>

 


 
Indinavir impairs endothelial function in healthy HIV-negative men and may accelerate [[atherosclerotic]] disease.<ref name="pmid16290967">Shankar SS, Dubé MP, Gorski JC, Klaunig JE, Steinberg HO. [https://www.ncbi.nlm.nih.gov/pubmed/16290967 Indinavir impairs endothelial function in healthy HIV-negative men.] Am Heart J. 2005 Nov;150(5):933.</ref>

 

